Intuitive Surgical (NASDAQ:ISRG) Releases Earnings Results, Beats Expectations By $0.26 EPS

Intuitive Surgical (NASDAQ:ISRG) released its quarterly earnings results on Thursday. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26, FiscalAI reports. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the prior year, the company posted $2.21 earnings per share. Intuitive Surgical’s revenue was up 18.8% compared to the same quarter last year.

Here are the key takeaways from Intuitive Surgical’s conference call:

• Intuitive delivered strong 2025 financial results—revenue rose 21% to $10.1B, pro forma operating margin ~37%, Proforma EPS up 22%, $2.5B free cash flow and $2.3B of share repurchases.
• Rapid platform adoption drove procedure growth—da Vinci procedures +18% (multi‑port +17%, single‑port +87%), Ion procedures +51%, and 1,721 systems placed in 2025 including 870 da Vinci 5 units, supporting higher utilization.
• Company is targeting ambulatory surgery centers and international expansion via refurbished da Vinci XIR systems and tailored economic programs to broaden access and capture ASC volume opportunities.
• 2026 outlook shows slower growth (da Vinci procedures guide 13%–15%) with margin headwinds—gross margin guide 67%–68% includes an expected ~1.2% net‑revenue tariff impact and pro forma OpEx growth of 11%–15%.
• Regional risks—intensifying competition and provincial tender preferences in China reduced win rates, and Ion placements declined in Q4 (42 vs. 69 prior year), creating near‑term capital and pricing pressure in those markets.

Intuitive Surgical Stock Up 0.4%

Shares of ISRG stock opened at $525.81 on Friday. The business has a fifty day simple moving average of $562.83 and a 200 day simple moving average of $511.86. The company has a market cap of $188.49 billion, a P/E ratio of 69.55, a P/E/G ratio of 4.26 and a beta of 1.67. Intuitive Surgical has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q4 results beat revenue and EPS estimates — Intuitive reported $2.87B revenue and $2.53 adjusted EPS, above Street estimates, driven by procedure growth and improved margins; the market reacted positively. Read More.
• Positive Sentiment: Procedure growth and recurring consumables remain the core growth engine — da Vinci procedure trends (mid‑teens growth) underpin recurring instrument & service revenue, supporting margin expansion and long‑term visibility. Read More.
• Positive Sentiment: Analysts remain constructive — multiple firms (including William Blair and Bank of America coverage) continue with Buy/Outperform views and above‑consensus price targets, supporting upside expectations. Read More.
• Neutral Sentiment: Company guidance signals deceleration but remains constructive — Intuitive expects procedure growth to moderate (guidance midpoint lower than recent quarters) and modest tariff headwinds; investors are parsing near‑term growth versus multi‑year opportunity. Read More.
• Neutral Sentiment: Full earnings disclosure & call available — the company press release and the earnings call transcript provide detail on margins, R&D spending and geographic trends for investors doing deeper due diligence. Read More. and Read More.
• Negative Sentiment: Tariff impact and rising operating expenses could weigh on margins — management flagged a larger tariff drag in 2026 and expects operating expenses to grow faster as R&D ramps, which may temper operating leverage near‑term. Read More.
• Negative Sentiment: Insider selling and mixed institutional moves noted — recent filings show significant insider sales and some large institutional reallocations, which investors may view as a caution signal to monitor. Read More.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent research reports. Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Leerink Partners boosted their price target on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, January 17th. Truist Financial upped their target price on Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a research report on Thursday, December 18th. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $622.58.

Insider Activity

In related news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares in the company, valued at $1,772,480. This represents a 81.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Brian Edward Miller sold 3,500 shares of the stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president directly owned 5,758 shares of the company’s stock, valued at approximately $3,310,850. The trade was a 37.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 55,714 shares of company stock valued at $31,617,799. Corporate insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ISRG. Prosperity Consulting Group LLC boosted its holdings in shares of Intuitive Surgical by 0.5% during the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after acquiring an additional 19 shares in the last quarter. CYBER HORNET ETFs LLC raised its position in Intuitive Surgical by 3.3% in the third quarter. CYBER HORNET ETFs LLC now owns 961 shares of the medical equipment provider’s stock valued at $430,000 after purchasing an additional 31 shares during the last quarter. Riggs Asset Managment Co. Inc. grew its holdings in shares of Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after purchasing an additional 32 shares during the last quarter. Quarry LP increased its stake in shares of Intuitive Surgical by 23.6% in the third quarter. Quarry LP now owns 173 shares of the medical equipment provider’s stock valued at $77,000 after buying an additional 33 shares during the period. Finally, Sivia Capital Partners LLC boosted its position in Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after buying an additional 34 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.